Strategic Research Collaborations

Strategic Research Collaborations

Our primary goal is to improve and push mental health care forward; to increase the (cost-)effectiveness of treatment and increase efficiency in treatment processes. We aim for a satisfactory therapeutic experience for the patient as well as the therapist. Patients will feel in charge, because active and passive sensing creates self-awareness, autonomy and self-directedness moving therapy forward in a natural and logical way. Because of this natural flow, therapists will be better facilitated to react and intervene in an appropriate way. We aim for precision therapy with its potential to optimize the effects of therapy and increase personal proficiency. The collaboration between patients and therapists will be equal and the principle of shared-decision making is leading.  

NiceDay has a track record of successful and innovative research projects in collaboration with cross-disciplinary organizations. We have experience with funding programs and have been awarded research grants from Dutch and European bodies including Eureka Eurostars, MIT R&D, FP7 and H2020 (in partnership with our parent company Almende).

Table of Contents

Research partners

We are actively looking for collaborations with members of:

  • Healthcare organizations (GGZ) willing to investigate and experiment with new and better ways of working and  participate in clinical trials,
  • Academic institutions aiming to contribute in the formulation of novel research hypotheses, build frameworks to model new theories in psychology,  and contribute to statistical analysis,
  • Tech companies willing to collaborate on applied research in healthcare such as by incorporating wearable technology in treatment and by developing decision support algorithms or tools,

If you belong to these organizations or if you don’t but can see a potential collaboration, send us a mail at

Reasons to join

Cooperation with us has the following advantages:

  • You can contribute to push online mental healthcare to the next level making it more effective for clients while keeping it cost-effective.
  • You can make use of our newly evidence-based developed treatment protocols.
  • You become a partner or lead new research projects - which can be tailored so that they match your research agenda - and
  • Receive funding for research and innovation when a grant is awarded.
  • You increase the visibility of your organization as a result of research publications and findings.
  • You can make direct use of the amended protocol and research results to:
    • improve treatment (cost-)effectiveness
    • reduce overhead for therapists and increase their job satisfaction
    • increase the therapeutic experience of therapists and patients.

We hope this collaboration will create a 'cycle of improvement', in which research output will continuously  generate new research ideas.


  • Team up in applications for grants and subsidies.
  • Collaborate in conducting research studies on topics that align our vision of improving mental healthcare.
  • Work together in the writing of peer-reviewed joint research publications.

In addition, we need full commitment from our GGZ partners during research and validation studies. This means the following:

  • Work according to the NiceDay Way protocols.
  • Collaborate with therapist training.
  • Enable OMQ and SMQ questionnaires to the clients on every session.
  • Make use of NiceDay tools such as treatment status, trackers and planned sessions.
  • Share treatment-related data (such as demographics, clinical variables and ROM outcomes) in accordance with GDPR and other EU regulations for scientific validation and research purposes.

Main Research Questions

In order to further validate and develop the NiceDay Way and generate evidence for this visionary way of working we have formulated the following research agenda:

  • Investigating to what extent the different unique factors of NiceDay (e.g. feedback informed treatment, outcome measurements, continuous registrations, ecological valid interventions, intermediate contact) add to the effectiveness of the intervention and prevent relapse.
  • Comparing the NiceDay sensing and logging in terms of disruptiveness, effectiveness, acceptability, feasibility and efficiency to other measurement approaches in the long-term.
  • Investigating if working according to the NiceDay Way promotes client’s autonomy and empowers them.
  • Investigating the (cost-) effectiveness of the NiceDay Way
  • Researching the use of wearable devices and biosensing technologies in healthcare treatments.
  • Evaluating the incorporation of decision support tools in treatment that make use of explainable AI systems. Some subjects include:
    • Investigating if active (trackers and registrations) and passive (sleeping and physical activity patterns) sensing via automatic feedback can promote mental well-being in the patient without interventions of the therapist; and can serve as a form of unguided maintenance therapy
    • Investigating if active (trackers and registrations) and passive (sleeping and physical activity patterns) sensing via automatic feedback provide therapists automatic feedback to detect ‘signal cases’, and on which interventions are needed to increase treatment effectiveness or reduce risk of relapse
    • Data-driven client prioritization tools for therapists that can provide early warning signals from clients and nudge therapists when to intervene.
    • Personalized coaching.